ÖZET Amaç: Bu çalışmanın amacı, etkin iyi planlanmış bir ekip yaklaşımının fibrinolitik tedavi almış akut ST-segment yükselmeli miyokart enfarktüslü (STEMİ) vakaların sağkalımına etkisini araştırmaktı. Yöntemler: Fibrinolitik tedavi akut STEMI'lı olgularda akılcı bir seçenek olmaya devam etmektedir. Fibrinolitik tedavi alan STEMI'lı olguların kısa sürede tedaviye ulaşmalarının mortalitelerini azalttığı defalarca gösterilmiştir. Nisan 2007'de iyi planlanmış bir ekip yaklaşımı başlatıldı. Sosyodemografik, klinik, laboratuvar ve zaman ölçümleri gibi bilgiler 109 çalışma hastasında prospektif olarak, 2005-2007 yıllarından 155 kontrol hastasında retrospektif olarak toplandı. Olguyu tartışmak için tek telefon konuşması yapıldı. Acil değerlendirme kesin olgularda yapılmadı. Şüpheli olgularda EKG'ler kardiyoloğa fakslandı. Kapı-iğne zamanları medyan olarak hesaplandı. Mortalite oranları kliniğe kontrole gelen hastalarda kayıtlar incelenerek, diğer tüm hastalarda telefon görüşmeleri ile belirlendi. Kapı-iğne zamanları Mann-Whitney U testi ile karşılaştırıldı. Altı aylık mortaliteler Fischer'in tam testi ile karşılaştırıldı. Bulgular: Çalışma grubunda kapı-iğne aralığı başvurma zamanından bağımsız anlamlı olarak azaldı (mesai dışında 59 dakikadan 29 dakikaya azaldı) (mesai içinde 35 dakikadan 18 dakikaya azaldı) (p<0.0001). Mortalite çalışma grubunda (2 ölüm, %1.8) kontrol grubu (12 ölüm, %7.7) ile karşılaştırıldığında anlamlı olarak azaldı (p=0.048). Sonuç: Akut ST yükselmeli miyokart enfarktüsü ile başvuran ve fibrinolitik tedavisi uygulanan hastaların ölüm oranları optimal hastane planlaması ile azalmıştır. (Anadolu Kardiyol Derg 2010 Aralık 1; 10(6): 508-13) Anahtar kelimeler: ST segment yükselmeli miyokart enfarktüsü, mortalite, iyi planlanmış ekip yaklaşımı ABSTRACT Objective: Fibrinolytic therapy remains a legitimate option for many patients presenting with acute ST-segment elevation myocardial infarction (STEMI). Shorter time-to-treatment for patients with STEMI administered fibrinolytic therapy has repeatedly been shown to reduce mortality. A well-organized collaborative team approach was implemented in April 2007. The purpose of this study was to examine the effect of implementing a well-organized collaborative team approach on the outcome in patients with acute STEMI treated with fibrinolysis. Methods: Sociodemographic, clinical, laboratory, and time interval data were prospectively collected on 109 consecutive patients (the study group) and 155 patients from the years 2005-2007 (the control group) retrospectively. A single-phone call was made to discuss case. Emergency department evaluation was bypassed for definitive case. An electrocardiogram was faxed to the on-call cardiologist for suspected case. Doorto-needle times were calculated as medians. Mortality was assessed by reviewing records of all patients visiting outpatient clinic. For the rest, information was obtained over the phone. Median door-to-needle times were compared using Mann-Whitney U test. The Fisher's exact test was used to compare 6-month mortalities. Results: Improvements were seen in door-to-needle times in the study group regardless of time of presentation (reduced from 59 minutes to 29 minutes during off hours) (reduced from 35 minutes to 18 minutes during regular hours) (p<0.0001). Mortality was significantly reduced in the study group (2 deaths, 1.8%) compared with the control group (12 deaths, 7.7%, p=0.048). Conclusion: The mortality of patients presenting with acute STEMI treated with fibrinolytic therapy was significantly reduced after optimal hospital organization. (Anadolu Kardiyol Derg 2010 December 1; 10(6): 508-13)
Introduction
Mortality from ST-segment elevation myocardial infarction (STEMI) remains high. Shorter time to reperfusion in patients with STEMI treated with fibrinolytic therapy is associated with better survival (1) (2) (3) (4) .
The rapid restoration of sustained patency of the infarctrelated artery with low residual stenosis is the primary goal of treatment. This can be achieved by prompt use of either fibrinolytic therapy or primary angioplasty. Even in the Western worldwide application of a primary angioplasty strategy to the majority of patients with acute myocardial infarction (MI) is not feasible. Yet almost one-third of eligible patients is not given any reperfusion therapy at all (5) . For many such patients, fibrinolytic therapy remains a legitimate option. Published guidelines recommend a goal of 30 minutes for presentation at the hospital to the administration of fibrinolytic therapy (door-to-needle time) (6) . No contemporary report exists about state or university hospital performance in achieving this goal for time to reperfusion in Turkey. In addition, the relation between the time to treatment and optimal hospital organization, and its impact on outcome have not been well studied.
Accordingly, the aim of this report was to examine the clinical outcome after the implementation of a well-organized collaborative team approach in patients with acute MI treated with fibrinolysis.
Methods
Study design and patient's characteristics Patients (n=109) who presented to Servergazi State Hospital with STEMI, received fibrinolytic therapy as the reperfusion strategy and were managed according to collaborative approach (since April 2007, see below) comprised the study group (prospective follow-up group). Patients presenting with ongoing chest pain of ≤12 h in duration with ECG criteria of ST-segment elevation ≥0.1 mm in two or more electrocardiographic leads were assigned to receive either streptokinase or tissue-plasminogen activator (t-PA). Patients presenting with uncomplicated inferior MI with onset of symptoms within 3 hours before the initiation of therapy had received streptokinase. All other patients had received t-PA. Patients with previous MI, prior coronary stenting or coronary artery bypass grafting (CABG), previous history of angina pectoris, chronic renal insufficiency, chronic obstructive pulmonary disease, stroke, Killip class >1, current smoking status, heart rate ≥120 bpm were excluded. Patients who had developed stroke, re-ischemia, reinfarction, or died during index hospitalization were also excluded. Electronic records of all patients who visited our outpatient clinic were reviewed. For all other patients, information was obtained by direct telephone interview with the patient or relative.
One hundred and fifty five patients with similar demographic and clinical characteristics who had been treated with fibrinolytic therapy between August 2005 and March 2007 served as controls (restrospective analysis group).
All patients had received aspirin, β blockers, angiotensinconverting enzyme inhibitors/ angiotensin receptor blockers, and statins while at the hospital and after discharge unless they were not tolerated or contraindicated. Clopidogrel could only be given for a month after discharge due to government's reimbursement policies.
Collaborative team approach protocol ( Fig. 1 ) We implemented a protocol to improve timeliness of reperfusion therapy.
The protocol was implemented in April 2007 and included the following strategies: (1) single-phone call for the on-call cardiologist and the emergency room (ER) physician to discuss case;
(2) bypassing of emergency department evaluation for definitive case; (3) Electrocardiograms were faxed to the on-call cardiologist for suspected case; (4) multiple consultations were avoided; (5) Coronary care unit (CCU) and ER staff were educated and trained by a cardiologist; (6) One of the elevators was assigned for emergency use only; (7) Transfer of patients carried out by the CCU personnel.
The time period from hospital arrival to time of therapy can be influenced readily by changes in hospital practice patterns (7) . Our well-organized collaborative team approach is shown in Figure 1 . A cardiologist had seen patients when asked during regular hours (8 AM to 5 PM Monday through Friday), and after a decision for pharmacologic reperfusion was made then the patient was admitted to the CCU. When 112 was contacted for a patient during off hours (5 PM to 8 AM and at weekends), and if there was no question regarding diagnosis after initial evaluation by 112 personnel or ER personnel, the patient was admitted to the CCU. Suspected cases were also brought to the ER by 112 for further evaluation, and ER physicians contacted the cardiologist on call. Electrocardiograms (ECG) were faxed to an off-site cardiologist's notebook for confirmation. Multiple consultations were avoided. Based on the discussion with a cardiologist, a decision for pharmacologic or catheter based therapy was made. In-hospital treatment delay has been shortened to ≈20-30 min by establishing special in-hospital structures (8) . The CCU and ER staff were educated and trained specifically on ECG findings and treatment of acute STEMI. One of the elevators was assigned to emergency use only. The transfer of the patients was carried out by the CCU staff.
Before April 2007, the protocol strategies were not used routinely at Servergazi State Hospital. Patients who served as controls underwent emergency department evaluation. Multiple consultations were made. Some ER personnel were unaware of treatment delays associated with increased mortality in patients with STEMI treated with fibrinolytic therapy. Previously, ECGs were faxed from the CCU instead of the ER. No elevator was assigned for emergency use only. Most patients were transferred to the CCU by busy ER staff. All of these had caused additional delays in time to treatment.
Data collection
Our main outcome measure was 6-month mortality. Data were obtained on all 264 patients admitted with STEMI and received fibrinolytic therapy. Time-to-treatment for fibrinolytic therapy was measured with door-to-needle (DTN) time. DTN time is the time in minutes between first hospital arrival and the delivery of reperfusion therapy. DTN times were calculated as medians. Patient demographic and clinical characteristics included sociodemographic variables (gender, age); medical history (hypertension, diabetes, dyslipidemia); the admission time of day (day, evening, or night); and admission day of week (weekday or weekend), the presence of chest pain, the location of myocardial infarction, the fibrinolytic agent used, the percentages of post-fibrinolytic TIMI-3 flow, and post-fibrinolytic CABG.
Angiographic data analysis All angiograms were analyzed by an experienced interventional cardiologist blinded to all data apart from the coronary angiogram. TIMI (Thrombolysis In Myocardial Infarction) flow was assessed, as described previously (9) .
Clinical outcomes
Records of all patients who visited our outpatient clinic were reviewed. For all other patients, information was obtained by direct telephone interview with the patient. At approximately 6 months after hospital discharge, patients were contacted to ascertain vital status. 
Statistical analysis
Statistical analysis was conducted using SPSS version 15.0 for Windows (SPSS Inc., Chicago, IL, USA). Median door-toneedle times in the control (pre-protocol) and the study (postprotocol) groups were compared using a Mann-Whitney U test. The Fisher's exact test was used to compare pre-protocol and post-protocol 6-month mortalities. Statistical significance was set at a level of p<0.05.
Results
The characteristics of the patients in the study group (n=109) and the control group (n=155) are displayed in Table 1 . Both groups had similar ages and similar percentages of men, hypertension, diabetes, dyslipidemia, chest pain, and anterior wall infarctions on presentation, the use of streptokinase as the fibrinolytic agent, and similar percentages of TIMI-3 flow restoration, and the need for coronary artery bypass grafting. Time interval measurements according to time of day are presented in Table 2 . For groups the study and the control, median (25th and 75th percentiles) door-toneedle times were 29 (19, 37) and 59 (31, 93) minutes during off hours (p<0.0001); 18 (12, 26) and 35 (22, 74) minutes during regular hours (p<0.0001), respectively.
Mortality was significantly reduced in the study group (2 deaths, 1.8%) compared with the control group (12 deaths, 7.7%, p=0.048) ( Table 1 ).
Discussion
The principal novel finding of this study was that by reducing time to treatment with the implementation of a well-organized in-hospital pharmacological reperfusion strategy, we have positively influenced our patients' outcomes.
Treatment with fibrinolytic therapy remains the most common mode of reperfusion for patients presenting with STEMI (10, 11) . Yet fibrinolytic therapy is a missed opportunity for many patients, especially those in rural areas, requiring long transportation times to the referral hospitals. Fibrinolytic agents are most effective when administered within 2 to 3 hours from symptom onset (12) (13) (14) (15) with longer treatment delays leading to worse clinical outcomes (16) . Because it requires at least an additional 30-45 minutes from the beginning of treatment until successful vessel reperfusion (17) . Time-to-treatment for STEMI are still prolonged. Throughout the last decade, time-to-treatment remained unchanged for patients treated with fibrinolysis (18) . Infarct size is significantly affected by the duration of coronary occlusion (19) (20) (21) . Therefore, late reperfusion is expected to result in less myocardial salvage and a higher mortality rate. De Luca et al. (22) found that patients with successful reperfusion had a significantly shorter ischemic time. Early reperfusion with fibrinolytic therapy in patients with evolving acute myocardial infarction (MI) has been clearly demonstrated to reduce mortality and salvage myocardium (23) .
Early and sustained patency of the infarct-related artery has been related to improved in-hospital and late survival (24, 25) , recovery of left ventricular function (24, (26) (27) (28) , prevention of ventricular aneurysm formation (29) , and cardiac rupture (30) , and enhanced electrical stability (31) . In addition, previous studies have demonstrated that only the acute restoration of TIMI grade 3 flow, present in ≈50% to 60% of vessels after fibrinolysis, is independently predictive of in-hospital survival and reduction in infarct size (26, 32, 33) . It has been demonstrated that treatment delays with fibrinolytic therapy were associated with higher 6-month mortality in patients with STEMI receiving reperfusion therapy. Our study showed that mortality was significantly reduced in the study group compared with the control group after the initiation of an optimal hospital organization. There was a significant reduction in DTN times after the introduction of the protocol. These included earlier transfer of fibrinolytic eligible patients from the field to the coronary care unit equipped for such therapy with an experienced staff, single-call activation of the CCU, and a wellorganized team-based approach with direct routing of patients to the CCU. These measures are consistent with the strategies articulated by the door-to-treatment time workgroup (34) . In addition, by earlier notification of a cardiologist, unnecessary multiple consultations were avoided. Emergency room and CCU personnel were specifically trained. All these measures helped reduce time to treatment consistent with a previous report, which showed that in-hospital delay has been shortened by establishing special in-hospital structures (8) . Thus, one explanation for our finding is a greater extent of early myocardial salvage as the result of a shorter time to treatment. In an animal study, it has been shown that the final infarct size is very sensitive to the duration of ischemia before reperfusion (20) . The ischemia time to recanalization also affects the severity of microvascular damage (35) . It has also been shown that there was a progressive decline in the extent of myocardium salvaged as the interval between symptoms and therapy increased (36) . Earlier treatment that improves myocardial (microvascular) reperfusion might have enhanced our patients' survival.
Thus, all efforts should be made to shorten total ischemic time. Coordinated efforts among community services, hospitals, and physicians will be necessary to achieve the goal of shortening time to treatment. Organizational culture, physician leadership, interrelationship between cardiology and emergency physicians and staff, emergency medical systems, and administrative support need to be identified and used by hospitals for performance improvement programs to decrease door-to-needle and decrease mortality from STEMI. Resources should be directed to early recognition of the acute myocardial infarction, improved utilization of emergency services for transportation, and prehospital diagnosis and triaging. The literature would suggest that prehospital 12-lead electrocardiogram and advanced emergency department notification reduces in hospital time to fibrinolysis (37) . McNamara et al. (11) found that improving time to fibrinolytic therapy could have an important effect on improving survival rates for patients presenting with STEMI. Our results also further highlight the importance of reducing the time delay between symptom onset and the initiation of thrombolytic therapy in patients with AMI. Meaningful reductions in fibrinolytic treatment times can be achieved with a better organization at an institutional level. Moreover, this could translate into better patient outcomes.
Study limitations
Several limitations of this study should be mentioned. Its limited sample size is one of the weaknesses of the study. Information was obtained by direct telephone interview with patients who had not visited our outpatient clinic. Thus, we largely relied on their recollection for the events. Time to treatment was calculated from when the patient was first registered with the front desk in the ER to the initiation of fibrinolytic therapy in the CCU. Sometimes registration took place after patients' transfer from the ER. Some patients might have discontinued their medications (beta-blockers, ACE-Is, statins) for some reason against our advice.
Conclusion
We implemented a protocol and achieved door-to-needle times that were close to what is recommended in the guidelines. We showed that mortality of patients presenting with STEMI was significantly reduced after a well-organized collaborative team approach has been implemented. We demonstrated that novel and simple strategies and coordination of systems of care make these times achievable and improve patients' outcomes. Since fibrinolytic therapy remains the most accessible therapy for such patients, a well-organized collaborative team approach can be broadly applied to decrease their mortality.
